Cencora | Sustainability Performance
Distributes pharmaceutical products and provides healthcare solutions to pharmacies and providers.
1985
United States
10,001+ employees
Wholesale
$10B+ in revenue
$1B - 10B in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#6788
Overallⓘ#1450
in United Statesⓘ#46
in WholesaleⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Leading
Leading
Critical
Intensity
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Water consumption intensity (m³ /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark
144.4
B/M 565.9
6.2
B/M 22.2
0.2
B/M 0.9
Powered by illuminem and GIST Impact
Controversy level
- Cencora (formerly AmerisourceBergen) was named in major US opioid settlement, paying USD 6.4 billion as part of the USD 26 billion national opioid settlement framework alongside McKesson and Cardinal Health.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.